These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 33440724)

  • 1. The Fatty Acid Lipid Metabolism Nexus in COVID-19.
    Tanner JE; Alfieri C
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33440724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
    Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
    Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.
    Williams CG; Jureka AS; Silvas JA; Nicolini AM; Chvatal SA; Carlson-Stevermer J; Oki J; Holden K; Basler CF
    Cell Rep; 2021 Aug; 36(5):109479. PubMed ID: 34320401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals.
    Shukla A; Singh A; Tripathi S
    J Am Nutr Assoc; 2024; 43(7):614-626. PubMed ID: 38805016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
    Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
    PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective inhibition of coronavirus replication by
    Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
    [No Abstract]   [Full Text] [Related]  

  • 8. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
    Schreiber A; Viemann D; Schöning J; Schloer S; Mecate Zambrano A; Brunotte L; Faist A; Schöfbänker M; Hrincius E; Hoffmann H; Hoffmann M; Pöhlmann S; Rescher U; Planz O; Ludwig S
    Cell Mol Life Sci; 2022 Jan; 79(1):65. PubMed ID: 35013790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty Acid Synthase Is Involved in Classical Swine Fever Virus Replication by Interaction with NS4B.
    Liu YY; Liang XD; Liu CC; Cheng Y; Chen H; Baloch AS; Zhang J; Go YY; Zhou B
    J Virol; 2021 Aug; 95(17):e0078121. PubMed ID: 34132567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
    van de Leemput J; Han Z
    Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells.
    Du L; Deiter F; Bouzidi MS; Billaud JN; Simmons G; Dabral P; Selvarajah S; Lingappa AF; Michon M; Yu SF; Paulvannan K; Manicassamy B; Lingappa VR; Boushey H; Greenland JR; Pillai SK
    Commun Biol; 2024 Apr; 7(1):486. PubMed ID: 38649430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifaceted Role of AMPK in Viral Infections.
    Bhutta MS; Gallo ES; Borenstein R
    Cells; 2021 May; 10(5):. PubMed ID: 34066434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
    Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus.
    Terrier O; Dilly S; Pizzorno A; Chalupska D; Humpolickova J; Bouřa E; Berenbaum F; Quideau S; Lina B; Fève B; Adnet F; Sabbah M; Rosa-Calatrava M; Maréchal V; Henri J; Slama-Schwok A
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target.
    Renz A; Widerspick L; Dräger A
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34073716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
    Rogosnitzky M; Okediji P; Koman I
    Pharmacol Rep; 2020 Dec; 72(6):1509-1516. PubMed ID: 32700247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.